{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:30:13Z","timestamp":1791639013651,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001 \u2013 Masters Scholarship - Grant number 1693097"],"award-info":[{"award-number":["Finance Code 001 \u2013 Masters Scholarship - Grant number 1693097"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Trichomonas vaginalis<\/jats:italic>is the causative agent of trichomoniasis, which is one of the most common sexually transmitted diseases worldwide. Trichomoniasis has a high incidence and prevalence and is associated with serious complications such as HIV transmission and acquisition, pelvic inflammatory disease and preterm birth. Although trichomoniasis is treated with oral metronidazole (MTZ), the number of strains resistant to this drug is increasing (2.5\u20139.6%), leading to treatment failure. Therefore, there is an urgent need to find alternative drugs to combat this disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Herein, we report the<jats:italic>in vitro<\/jats:italic>and<jats:italic>in silico<\/jats:italic>analysis of 12 furanyl<jats:italic>N<\/jats:italic>-acylhydrazone derivatives (PFUR 4, a-k) against<jats:italic>Trichomonas vaginalis<\/jats:italic>.<jats:italic>Trichomonas vaginalis<\/jats:italic>ATCC 30236 isolate was treated with seven concentrations of these compounds to determine the minimum inhibitory concentration (MIC) and 50% inhibitory concentration (IC<jats:sub>50<\/jats:sub>). In addition, compounds that displayed anti-<jats:italic>T. vaginalis<\/jats:italic>activity were analyzed using thiobarbituric acid reactive substances (TBARS) assay and molecular docking. Cytotoxicity analysis was also performed in CHO-K1 cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The compounds PFUR 4a and 4b, at 6.25 \u00b5M, induced complete parasite death after 24 h of exposure with IC<jats:sub>50<\/jats:sub>of 1.69 \u00b5M and 1.98 \u00b5M, respectively. The results showed that lipid peroxidation is not involved in parasite death. Molecular docking studies predicted strong interactions of PFUR 4a and 4b with<jats:italic>T. vaginalis<\/jats:italic>enzymes, purine nucleoside phosphorylase, and lactate dehydrogenase, while only PFUR 4b interacted<jats:italic>in silico<\/jats:italic>with thioredoxin reductase and methionine gamma-lyase. PFUR 4a and 4b led to a growth inhibition (&lt;\u200920%) in CHO-K1 cells that was comparable to the drug of choice, with a promising selectivity index (&gt;\u20097.4).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results showed that PFUR 4a and 4b are promising molecules that can be used for the development of new trichomonacidal agents for<jats:italic>T. vaginalis<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13071-020-3923-8","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T16:02:50Z","timestamp":1581436970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0754-3721","authenticated-orcid":false,"given":"Mirna Samara Di\u00e9","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Nascimento","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngela","family":"Sena-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Casaril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Vieira","family":"Segatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Cristina Mendon\u00e7a","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius Nora","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucielli","family":"Savegnago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana K\u00f6mmling","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Collares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibele","family":"Borsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"3923_CR1","unstructured":"WHO. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: World Health Organization; 2012. https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/stisestimates\/en\/. Accessed 31 Aug 2019."},{"key":"3923_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/trstmh\/trt063","volume":"107","author":"DF Grama","year":"2013","unstructured":"Grama DF, da Casarotti LS, de Morato MGVA, Silva LS, Mendon\u00e7a DF, Limongi JE, et al. Prevalence of Trichomonas vaginalis and risk factors in women treated at public health units in Brazil: a transversal study. Trans R Soc Trop Med Hyg. 2013;107:584\u201391.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"3923_CR3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/0956462414523742","volume":"25","author":"DAP Rocha","year":"2014","unstructured":"Rocha DAP, Filho RAAB, Mari\u00f1o JM, dos Santos CMB. \u201cHidden\u201d sexually transmitted infections among women in primary care health services, Amazonas, Brazil. Int J STD AIDS. 2014;25:878\u201386.","journal-title":"Int J STD AIDS."},{"key":"3923_CR4","first-page":"86","volume":"27","author":"MP Bruni","year":"2015","unstructured":"Bruni MP, Lopes S, Stauffert D, Caetano C, Filho C, Siqueira L, et al. Trichomonas vaginalis infection among women attending frequency, risk factors and clinical signs. DST-J bras Doen\u00e7as Sex Transm. 2015;27:86\u201391.","journal-title":"DST-J bras Doen\u00e7as Sex Transm."},{"key":"3923_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S1678-9946201658061","volume":"58","author":"CL Ambrozio","year":"2016","unstructured":"Ambrozio CL, Nagel AS, Jesk S, Bragan\u00e7a GCM, Borsuk S, Villela MM. Trichomonas vaginalis prevalence and risk factors for women in southern Brazil. Rev Inst Med Trop Sao Paulo. 2016;58:1\u20135.","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"3923_CR6","doi-asserted-by":"publisher","first-page":"e0173604","DOI":"10.1371\/journal.pone.0173604","volume":"12","author":"FA Dos Gatti","year":"2017","unstructured":"Dos Gatti FA, Ceolan E, Greco FSR, Santos PC, Klafke GB, de Oliveira GR, et al. The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil. PLoS ONE. 2017;12:e0173604.","journal-title":"PLoS ONE."},{"key":"3923_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/sextrans-2013-051075","volume":"89","author":"DN Poole","year":"2013","unstructured":"Poole DN, McClelland RS. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect. 2013;89:418\u201322.","journal-title":"Sex Transm Infect."},{"key":"3923_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.15698\/mic2016.09.526","volume":"3","author":"CB Menezes","year":"2016","unstructured":"Menezes CB, Frasson AP, Tasca T. Trichomoniasis\u2014are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell. 2016;3:404\u201318.","journal-title":"Microb Cell."},{"key":"3923_CR9","doi-asserted-by":"publisher","first-page":"S837","DOI":"10.1093\/cid\/civ738","volume":"61","author":"E Meites","year":"2015","unstructured":"Meites E, Gaydos CA, Hobbs MM, Kissinger P, Nyirjesy P, Schwebke JR, et al. A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infections. Clin Infect Dis. 2015;61:S837\u201348.","journal-title":"Clin Infect Dis."},{"key":"3923_CR10","unstructured":"FDA. FDA approved drug products. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/. Accessed 31 Aug 2019."},{"key":"3923_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2958.2009.06675.x","volume":"72","author":"D Leitsch","year":"2009","unstructured":"Leitsch D, Kolarich D, Binder M, Stadlmann J, Altmann F, Duch\u00eane M. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system Implications for nitroimidazole toxicity and resistance. Mol Microbiol. 2009;72:518\u201336.","journal-title":"Mol Microbiol."},{"key":"3923_CR12","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1128\/AAC.00814-06","volume":"50","author":"JR Schwebke","year":"2006","unstructured":"Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother. 2006;50:4209\u201310.","journal-title":"Antimicrob Agents Chemother."},{"key":"3923_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3201\/eid1806.111590","volume":"18","author":"RD Kirkcaldy","year":"2012","unstructured":"Kirkcaldy RD, Augostini P, Asbel LE, Bernstein KT, Kerani RP, Mettenbrink CJ, et al. Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD surveillance network, 2009\u20132010. Emerg Infect Dis. 2012;18:939\u201343.","journal-title":"Emerg Infect Dis."},{"key":"3923_CR14","volume-title":"Sexually transmitted diseases treatment guidelines, 2015. MMWR recommended reports","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR recommended reports. Atlanta: Center for Disease Control; 2015."},{"key":"3923_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1258\/0956462053654258","volume":"16","author":"S Das","year":"2005","unstructured":"Das S, Huengsberg M, Shahmanesh M. Treatment failure of vaginal trichomoniasis in clinical practice. Int J STD AIDS. 2005;16:284\u20136.","journal-title":"Int J STD AIDS."},{"key":"3923_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0166-6851(02)00330-4","volume":"127","author":"NR Munagala","year":"2003","unstructured":"Munagala NR, Wang CC. Adenosine is the primary precursor of all purine nucleotides in Trichomonas vaginalis. Mol Biochem Parasitol. 2003;127:143\u20139.","journal-title":"Mol Biochem Parasitol."},{"key":"3923_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/iub.255","volume":"61","author":"D Sato","year":"2009","unstructured":"Sato D, Nozaki T. Methionine gamma-lyase: the unique reaction mechanism, physiological roles, and therapeutic applications against infectious diseases and cancers. IUBMB Life. 2009;61:1019\u201328.","journal-title":"IUBMB Life."},{"key":"3923_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/scipharm85010005","volume":"85","author":"M Setzer","year":"2017","unstructured":"Setzer M, Byler K, Ogungbe I, Setzer W. Natural products as new treatment options for trichomoniasis: a molecular docking investigation. Sci Pharm. 2017;85:5.","journal-title":"Sci Pharm."},{"key":"3923_CR19","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1016\/j.bmc.2016.09.013","volume":"24","author":"JM Dos Santos Filho","year":"2016","unstructured":"Dos Santos Filho JM, de Queiroz E Silva DMA, Macedo TS, Teixeira HMP, Moreira DRM, Challal S, et al. Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents. Bioorganic Med Chem. 2016;24:5693\u2013701.","journal-title":"Bioorganic Med Chem."},{"key":"3923_CR20","doi-asserted-by":"publisher","first-page":"e85380","DOI":"10.1371\/journal.pone.0085380","volume":"9","author":"DN Do Amaral","year":"2014","unstructured":"Do Amaral DN, Cavalcanti BC, Bezerra DP, Ferreira PMP, De Castro RP, Sabino JR, et al. Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues. PLoS ONE. 2014;9:e85380.","journal-title":"PLoS ONE."},{"key":"3923_CR21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1590\/S0100-40422012000800014","volume":"35","author":"TH Cachiba","year":"2012","unstructured":"Cachiba TH, Carvalho BD, Carvalho DT, Cusinato M, Prado CG, Dias ALT. S\u00edntese e avalia\u00e7\u00e3o preliminar da atividade antibacteriana e antif\u00fangica de derivados N-acilidraz\u00f4nicos. Quim Nova. 2012;35:1566\u20139.","journal-title":"Quim Nova."},{"key":"3923_CR22","doi-asserted-by":"publisher","first-page":"e0185783","DOI":"10.1371\/journal.pone.0185783","volume":"12","author":"H Zhang","year":"2017","unstructured":"Zhang H, Kunadia A, Lin Y, Fondell JD, Seidel D, Fan H. Identification of a strong and specific antichlamydial N-acylhydrazone. PLoS ONE. 2017;12:e0185783.","journal-title":"PLoS ONE."},{"key":"3923_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF00531499","volume":"29","author":"E Lukevits","year":"1993","unstructured":"Lukevits E, Demicheva L. Biological activity of furan derivatives (review). Chem Heterocycl Compd. 1993;29:243\u201367.","journal-title":"Chem Heterocycl Compd."},{"key":"3923_CR24","first-page":"7","volume":"2","author":"R Banerjee","year":"2012","unstructured":"Banerjee R, Kumar HKS, Banerjee M. Medicinal significance of furan derivatives: a review. Int J Rev Life Sci. 2012;2:7\u201316.","journal-title":"Int J Rev Life Sci."},{"key":"3923_CR25","first-page":"395","volume-title":"In: Comprehensive heterocyclic chemistry II, a review of literature 1982\u20131995: the structure, reactions, synthesis, and uses of heterocyclic compounds","author":"BA Keay","year":"1996","unstructured":"Keay BA, Dibble PW. In: Katritzky AR, Rees CW, Scriven EFV, editors. In: Comprehensive heterocyclic chemistry II, a review of literature 1982\u20131995: the structure, reactions, synthesis, and uses of heterocyclic compounds. 1st ed. Oxford: Pergamon Press; 1996. p. 395\u2013436.","edition":"1"},{"key":"3923_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.13171\/mjc.5.1\/0160213\/desouza","volume":"5","author":"LN de Faria Cardoso","year":"2016","unstructured":"de Faria Cardoso LN, Nogueira TCM, Kaiser CR, Wardell JL, Wardell SMSV, de Souza MVN. Synthesis and anti-tubercular activity of thienyl and furanyl derivatives. Mediterr J Chem. 2016;5:356\u201366.","journal-title":"Mediterr J Chem."},{"key":"3923_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2307\/3274682","volume":"43","author":"LS Diamond","year":"1957","unstructured":"Diamond LS. The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol. 1957;43:488\u201390.","journal-title":"J Parasitol."},{"key":"3923_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.biopha.2017.01.173","volume":"89","author":"\u00c2 Sena-Lopes","year":"2017","unstructured":"Sena-Lopes \u00c2, das Neves RN, Bezerra FSB, de Oliveira Silva MT, Nobre PC, Perin G, et al. Antiparasitic activity of 1,3-dioxolanes containing tellurium in Trichomonas vaginalis. Biomed Pharmacother. 2017;89:284\u20137.","journal-title":"Biomed Pharmacother."},{"key":"3923_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1017\/S003118201800152X","volume":"146","author":"GV Rigo","year":"2019","unstructured":"Rigo GV, Petro-silveira B, Devereux M, Mccann M, Luis A, Tasca T. Anti-Trichomonas vaginalis activity of metallodrugs and synergistic effect with metronidazole. Parasitology. 2019;146:1179\u201383.","journal-title":"Parasitology."},{"key":"3923_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues thiobarbituric acid reaction. Anal Biochem. 1979;95:351\u20138.","journal-title":"Anal Biochem."},{"key":"3923_CR31","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013303.","journal-title":"Nucleic Acids Res."},{"key":"3923_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera? A visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem."},{"key":"3923_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem."},{"key":"3923_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4:17.","journal-title":"J Cheminform."},{"key":"3923_CR35","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u201391.","journal-title":"J Comput Chem."},{"key":"3923_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.biopha.2018.12.058","volume":"111","author":"C da Carapina Silva","year":"2019","unstructured":"da Carapina Silva C, Pacheco BS, das Neves RN, Di\u00e9 Alves MS, Sena-Lopes A, Moura \u00c2, et al. Antiparasitic activity of synthetic curcumin monocarbonyl analogues against Trichomonas vaginalis. Biomed Pharmacother. 2019;111:367\u201377.","journal-title":"Biomed Pharmacother."},{"key":"3923_CR37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1086\/511278","volume":"195","author":"RS McClelland","year":"2007","unstructured":"McClelland RS, Sangar\u00e9 L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195:698\u2013702.","journal-title":"J Infect Dis."},{"key":"3923_CR38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1086\/526496","volume":"197","author":"B Van Der Pol","year":"2008","unstructured":"Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen P-L, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197:548\u201354.","journal-title":"J Infect Dis."},{"key":"3923_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/OLQ.0b013e3181b38a4b","volume":"36","author":"JE Allsworth","year":"2009","unstructured":"Allsworth JE, Ratner JA, Peipert JF. Trichomoniasis and other sexually transmitted infections: results from the 2001\u20132004 national health and nutrition examination surveys. Sex Transm Dis. 2009;36:738\u201344.","journal-title":"Sex Transm Dis."},{"key":"3923_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12879-015-1055-0","volume":"15","author":"P Kissinger","year":"2015","unstructured":"Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015;15:307.","journal-title":"BMC Infect Dis."},{"key":"3923_CR41","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.1016\/j.bmc.2012.08.047","volume":"20","author":"JM dos Santos Filho","year":"2012","unstructured":"dos Santos Filho JM, Moreira DRM, de Simone CA, Ferreira RS, McKerrow JH, Meira CS, et al. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice. Bioorg Med Chem. 2012;20:6423\u201333.","journal-title":"Bioorg Med Chem."},{"key":"3923_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/1087057108323122","volume":"13","author":"A Meneses-Marcel","year":"2008","unstructured":"Meneses-Marcel A, Rivera-Borroto OM, Marrero-Ponce Y, Montero A, Machado Tugores Y, Escario JA, et al. New antitrichomonal drug-like chemicals selected by bond (edge)-based TOMOCOMD-CARDD descriptors. J Biomol Screen. 2008;13:785\u201394.","journal-title":"J Biomol Screen."},{"key":"3923_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/znc-2016-0129","volume":"72","author":"P Navin","year":"2017","unstructured":"Navin P, Sarvil P, Amit P, Divyesh P, Dhansukh R, Moo-Puc R, et al. Synthesis and biological evaluation of newer 1,3,4-oxadiazoles incorporated with benzothiazepine and benzodiazepine moieties. Zeitschr Naturforschung C. 2017;72:133\u201346.","journal-title":"Zeitschr Naturforschung C."},{"key":"3923_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0020-7519(98)00155-6","volume":"29","author":"J Kulda","year":"1999","unstructured":"Kulda J. Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol. 1999;29:199\u2013212.","journal-title":"Int J Parasitol."},{"key":"3923_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1590\/S0100-40422009000100032","volume":"32","author":"D Grotto","year":"2009","unstructured":"Grotto D, Maria LS, Valentini J, Paniz C, Schmitt G, Garcia SC, et al. Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quim Nova. 2009;32:169\u201374.","journal-title":"Quim Nova."},{"key":"3923_CR46","doi-asserted-by":"publisher","first-page":"22318","DOI":"10.1074\/jbc.M501843200","volume":"280","author":"Y Zang","year":"2005","unstructured":"Zang Y, Wang W-H, Wu S-W, Ealick SE, Wang CC. Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex. J Biol Chem. 2005;280:22318\u201325.","journal-title":"J Biol Chem."},{"key":"3923_CR47","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/bi061515r","volume":"46","author":"A Rinaldo-Matthis","year":"2007","unstructured":"Rinaldo-Matthis A, Wing C, Ghanem M, Deng H, Wu P, Gupta A, et al. Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues. Biochemistry. 2007;46:659\u201368.","journal-title":"Biochemistry."},{"key":"3923_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/31.1.9","volume":"31","author":"DI Edwards","year":"1993","unstructured":"Edwards DI. Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action. J Antimicrob Chemother. 1993;31:9\u201320.","journal-title":"J Antimicrob Chemother."},{"key":"3923_CR49","volume-title":"ISO 10993-5:2009-Biological evaluation of medical devices. Part 5: tests for in vitro cytotoxicity","author":"ISO-International Organazition for Standardization","year":"2009","unstructured":"ISO-International Organazition for Standardization. ISO 10993-5:2009-Biological evaluation of medical devices. Part 5: tests for in vitro cytotoxicity. Switzerland: International Organazition for Standardization; 2009."},{"key":"3923_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/ijms20020255","volume":"20","author":"O Jung","year":"2019","unstructured":"Jung O, Smeets R, Hartjen P, Schnettler R, Feyerabend F, Klein M, et al. Improved in vitro test procedure for full assessment of the cytocompatibility of degradable magnesium based on ISO 10993-5\/-12. Int J Mol Sci. 2019;20:255.","journal-title":"Int J Mol Sci."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-020-3923-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:48:27Z","timestamp":1722430107000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-3923-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3923"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-3923-8","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}